COMPOSITION FOR ALLEVIATING CORONAVIRUS INFECTION USING RALOXIFENE
The present invention discloses a composition for alleviating coronavirus infection using raloxifene which has an activity of improving the viability of infected cells of coronaviruses SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, or of inhibiting the propagation of the coronaviruses within...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention discloses a composition for alleviating coronavirus infection using raloxifene which has an activity of improving the viability of infected cells of coronaviruses SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, or of inhibiting the propagation of the coronaviruses within cells.
La présente invention concerne une composition pour soulager une infection à coronavirus à l'aide de raloxifène qui a une activité d'amélioration de la viabilité de cellules infectées par les coronavirus SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2, ou d'inhibition de la propagation des coronavirus dans les cellules.
본 발명은 코로나바이러스인 SARS-CoV, MERS-CoV, HCoV-229E, HCoV-OC43, SARS-CoV-2의 감염세포 생존율을 향상시키거나 그 코로나바이러스 세포 내 증식을 억제하는 활성을 가진 랄록시펜을 코로나바이러스 감염증 개선용 조성물을 개시한다. |
---|